Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
Gespeichert in:
| Veröffentlicht in: | Journal of gastroenterology and hepatology 2021-07, Vol.36 (7), p.2024-2025 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2025 |
|---|---|
| container_issue | 7 |
| container_start_page | 2024 |
| container_title | Journal of gastroenterology and hepatology |
| container_volume | 36 |
| creator | Dai, C Jiang, M Huang, Y‐h |
| description | |
| doi_str_mv | 10.1111/jgh.15526 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_proquest_journals_2551442520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2551442520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-8ef200327b8889695e28f05b90ccbc53996637266255e26b0e322986d9d19e453</originalsourceid><addsrcrecordid>eNqNkc1u1TAQhS0EopfCghdAltiAqrT-iR17WUXQH1ViA-socSbgq8QOdlK4Ox6BZ-RJmHJvu0BCYjYeab4ZHZ9DyEvOTjnW2fbzl1OulNCPyIaXJSt4VerHZMMMV4WV3B6RZzlvGWMlq9RTciSlMTisNmSu4zS3yecYaBxoXBcXJ8h3vdu5MeY5Jh-AntM29NSHYfTf_dR2dIiJ5gVS9P2vHz8TDKl1S0w72rp1AZrhFhLQdXSQ2sXfAnVx9IvPz8mToR0zvDi8x-TT-3cf68vi5sPFVX1-UzippC4MDIIxKarOGGO1VSDMwFRnmXOdU9JarWUltBYKR7pjIIWwRve25xZKJY_Jm_3dOcWvK-SlmXx2MI5tgLjmRiiuhRDGVIi-_gvdxjUFVIeUQkOFEgypt3vKpZgzfriZEzqRdg1nzV0MDcbQ_IkB2VeHi2s3Qf9A3vuOgNkD36CLQ3YegoMHDIPSpcDc0ALGeO0XtDCGOq5hwdWT_19F-uxA-xF2_5bcXF9c7rX_Bp9asoc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2551442520</pqid></control><display><type>article</type><title>Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Dai, C ; Jiang, M ; Huang, Y‐h</creator><creatorcontrib>Dai, C ; Jiang, M ; Huang, Y‐h</creatorcontrib><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/jgh.15526</identifier><identifier>PMID: 33880817</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Acute Disease ; Colitis, Ulcerative - drug therapy ; Cyclosporine - therapeutic use ; Cyclosporins ; Gastroenterology & Hepatology ; Gastrointestinal Agents - therapeutic use ; Humans ; Immunosuppressive Agents - therapeutic use ; Infliximab ; Infliximab - therapeutic use ; Life Sciences & Biomedicine ; Monoclonal antibodies ; Science & Technology ; Severity of Illness Index ; Steroids - therapeutic use ; Treatment Outcome ; Tumor necrosis factor-α ; Ulcerative colitis</subject><ispartof>Journal of gastroenterology and hepatology, 2021-07, Vol.36 (7), p.2024-2025</ispartof><rights>2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>2</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000642319200001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3536-8ef200327b8889695e28f05b90ccbc53996637266255e26b0e322986d9d19e453</citedby><cites>FETCH-LOGICAL-c3536-8ef200327b8889695e28f05b90ccbc53996637266255e26b0e322986d9d19e453</cites><orcidid>0000-0003-1317-183X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjgh.15526$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjgh.15526$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,39267,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33880817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dai, C</creatorcontrib><creatorcontrib>Jiang, M</creatorcontrib><creatorcontrib>Huang, Y‐h</creatorcontrib><title>Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis</title><title>Journal of gastroenterology and hepatology</title><addtitle>J GASTROEN HEPATOL</addtitle><addtitle>J Gastroenterol Hepatol</addtitle><subject>Acute Disease</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Cyclosporine - therapeutic use</subject><subject>Cyclosporins</subject><subject>Gastroenterology & Hepatology</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infliximab</subject><subject>Infliximab - therapeutic use</subject><subject>Life Sciences & Biomedicine</subject><subject>Monoclonal antibodies</subject><subject>Science & Technology</subject><subject>Severity of Illness Index</subject><subject>Steroids - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Tumor necrosis factor-α</subject><subject>Ulcerative colitis</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkc1u1TAQhS0EopfCghdAltiAqrT-iR17WUXQH1ViA-socSbgq8QOdlK4Ox6BZ-RJmHJvu0BCYjYeab4ZHZ9DyEvOTjnW2fbzl1OulNCPyIaXJSt4VerHZMMMV4WV3B6RZzlvGWMlq9RTciSlMTisNmSu4zS3yecYaBxoXBcXJ8h3vdu5MeY5Jh-AntM29NSHYfTf_dR2dIiJ5gVS9P2vHz8TDKl1S0w72rp1AZrhFhLQdXSQ2sXfAnVx9IvPz8mToR0zvDi8x-TT-3cf68vi5sPFVX1-UzippC4MDIIxKarOGGO1VSDMwFRnmXOdU9JarWUltBYKR7pjIIWwRve25xZKJY_Jm_3dOcWvK-SlmXx2MI5tgLjmRiiuhRDGVIi-_gvdxjUFVIeUQkOFEgypt3vKpZgzfriZEzqRdg1nzV0MDcbQ_IkB2VeHi2s3Qf9A3vuOgNkD36CLQ3YegoMHDIPSpcDc0ALGeO0XtDCGOq5hwdWT_19F-uxA-xF2_5bcXF9c7rX_Bp9asoc</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Dai, C</creator><creator>Jiang, M</creator><creator>Huang, Y‐h</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1317-183X</orcidid></search><sort><creationdate>202107</creationdate><title>Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis</title><author>Dai, C ; Jiang, M ; Huang, Y‐h</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-8ef200327b8889695e28f05b90ccbc53996637266255e26b0e322986d9d19e453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute Disease</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Cyclosporine - therapeutic use</topic><topic>Cyclosporins</topic><topic>Gastroenterology & Hepatology</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infliximab</topic><topic>Infliximab - therapeutic use</topic><topic>Life Sciences & Biomedicine</topic><topic>Monoclonal antibodies</topic><topic>Science & Technology</topic><topic>Severity of Illness Index</topic><topic>Steroids - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Tumor necrosis factor-α</topic><topic>Ulcerative colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dai, C</creatorcontrib><creatorcontrib>Jiang, M</creatorcontrib><creatorcontrib>Huang, Y‐h</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dai, C</au><au>Jiang, M</au><au>Huang, Y‐h</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><stitle>J GASTROEN HEPATOL</stitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2021-07</date><risdate>2021</risdate><volume>36</volume><issue>7</issue><spage>2024</spage><epage>2025</epage><pages>2024-2025</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>33880817</pmid><doi>10.1111/jgh.15526</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1317-183X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0815-9319 |
| ispartof | Journal of gastroenterology and hepatology, 2021-07, Vol.36 (7), p.2024-2025 |
| issn | 0815-9319 1440-1746 |
| language | eng |
| recordid | cdi_proquest_journals_2551442520 |
| source | MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | Acute Disease Colitis, Ulcerative - drug therapy Cyclosporine - therapeutic use Cyclosporins Gastroenterology & Hepatology Gastrointestinal Agents - therapeutic use Humans Immunosuppressive Agents - therapeutic use Infliximab Infliximab - therapeutic use Life Sciences & Biomedicine Monoclonal antibodies Science & Technology Severity of Illness Index Steroids - therapeutic use Treatment Outcome Tumor necrosis factor-α Ulcerative colitis |
| title | Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T02%3A58%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20outcomes%20of%20cyclosporine%20A%20and%20infliximab%20for%20steroid%E2%80%90refractory%20acute%20severe%20ulcerative%20colitis&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Dai,%20C&rft.date=2021-07&rft.volume=36&rft.issue=7&rft.spage=2024&rft.epage=2025&rft.pages=2024-2025&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/jgh.15526&rft_dat=%3Cproquest_webof%3E2551442520%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2551442520&rft_id=info:pmid/33880817&rfr_iscdi=true |